Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine |
| |
Authors: | Barreto L Guasparini R Meekison W Noya F Young L Mills E |
| |
Institution: | Sanofi Pasteur Limited, 1755 Steeles Avenue West, Toronto, Ontario M2R 3T4, Canada. luis.barreto@sanofipasteur.com |
| |
Abstract: | Persistence of antibodies following a single dose of Tdap vaccine (tetanus, diphtheria, and five-component acellular pertussis vaccine for use in individuals past childhood) was evaluated in a follow-up of adolescents (N=324) and adults (N=644) who had received Tdap in earlier clinical trials. Outcome measures were seroprotection (tetanus and diphtheria) or seropositivity (pertussis) and geometric mean titers. Humoral immune responses to all antigens were robust 1 month after initial immunization; antibodies exceeded pre-immunization levels 1, 3, and 5 years later. These data will contribute to selecting the optimal interval for booster doses of Tdap. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|